APYX vs. GROY
Compare and contrast key facts about Apyx Medical Corporation (APYX) and Gold Royalty Corp. (GROY).
Performance
APYX vs. GROY - Performance Comparison
Loading graphics...
APYX vs. GROY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
APYX Apyx Medical Corporation | 5.43% | 121.52% | -39.69% | 11.97% | -81.75% | 13.25% |
GROY Gold Royalty Corp. | -11.39% | 233.88% | -17.69% | -36.27% | -51.98% | 37.43% |
Fundamentals
APYX:
$155.58M
GROY:
$803.82M
APYX:
-$0.27
GROY:
-$0.02
APYX:
2.92
GROY:
43.27
APYX:
10.70
GROY:
1.15
APYX:
$52.10M
GROY:
$15.61M
APYX:
$33.04M
GROY:
$11.81M
APYX:
-$5.09M
GROY:
$6.29M
Returns By Period
In the year-to-date period, APYX achieves a 5.43% return, which is significantly higher than GROY's -11.39% return.
APYX
- 1D
- 3.07%
- 1M
- 12.84%
- YTD
- 5.43%
- 6M
- 72.43%
- 1Y
- 169.34%
- 3Y*
- 8.61%
- 5Y*
- -17.68%
- 10Y*
- —
GROY
- 1D
- 8.48%
- 1M
- -23.34%
- YTD
- -11.39%
- 6M
- -7.25%
- 1Y
- 148.61%
- 3Y*
- 18.56%
- 5Y*
- -3.88%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
APYX vs. GROY — Risk / Return Rank
APYX
GROY
APYX vs. GROY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and Gold Royalty Corp. (GROY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| APYX | GROY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.65 | 2.58 | -0.93 |
Sortino ratioReturn per unit of downside risk | 2.64 | 2.84 | -0.20 |
Omega ratioGain probability vs. loss probability | 1.31 | 1.35 | -0.04 |
Calmar ratioReturn relative to maximum drawdown | 5.05 | 3.76 | +1.29 |
Martin ratioReturn relative to average drawdown | 11.31 | 13.07 | -1.75 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| APYX | GROY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.65 | 2.58 | -0.93 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.18 | -0.07 | -0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.09 | 0.01 | -0.09 |
Correlation
The correlation between APYX and GROY is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
APYX vs. GROY - Dividend Comparison
Neither APYX nor GROY has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
APYX Apyx Medical Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GROY Gold Royalty Corp. | 0.00% | 0.00% | 0.00% | 1.36% | 1.72% |
Drawdowns
APYX vs. GROY - Drawdown Comparison
The maximum APYX drawdown since its inception was -94.99%, which is greater than GROY's maximum drawdown of -82.01%. Use the drawdown chart below to compare losses from any high point for APYX and GROY.
Loading graphics...
Drawdown Indicators
| APYX | GROY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.99% | -82.01% | -12.98% |
Max Drawdown (1Y)Largest decline over 1 year | -32.17% | -39.54% | +7.37% |
Max Drawdown (5Y)Largest decline over 5 years | -94.99% | -82.01% | -12.98% |
Current DrawdownCurrent decline from peak | -78.79% | -44.94% | -33.85% |
Average DrawdownAverage peak-to-trough decline | -56.43% | -56.15% | -0.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.25% | 11.37% | +4.88% |
Volatility
APYX vs. GROY - Volatility Comparison
Apyx Medical Corporation (APYX) has a higher volatility of 25.51% compared to Gold Royalty Corp. (GROY) at 18.65%. This indicates that APYX's price experiences larger fluctuations and is considered to be riskier than GROY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| APYX | GROY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.51% | 18.65% | +6.86% |
Volatility (6M)Calculated over the trailing 6-month period | 55.45% | 43.16% | +12.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 103.25% | 57.87% | +45.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 98.94% | 58.37% | +40.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 93.04% | 60.03% | +33.01% |
Financials
APYX vs. GROY - Financials Comparison
This section allows you to compare key financial metrics between Apyx Medical Corporation and Gold Royalty Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
APYX vs. GROY - Profitability Comparison
APYX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Apyx Medical Corporation reported a gross profit of 12.00M and revenue of 18.42M. Therefore, the gross margin over that period was 65.2%.
GROY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Gold Royalty Corp. reported a gross profit of 2.95M and revenue of 4.50M. Therefore, the gross margin over that period was 65.6%.
APYX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Apyx Medical Corporation reported an operating income of 11.00K and revenue of 18.42M, resulting in an operating margin of 0.1%.
GROY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Gold Royalty Corp. reported an operating income of 105.00K and revenue of 4.50M, resulting in an operating margin of 2.3%.
APYX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Apyx Medical Corporation reported a net income of -1.22M and revenue of 18.42M, resulting in a net margin of -6.6%.
GROY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Gold Royalty Corp. reported a net income of -920.00K and revenue of 4.50M, resulting in a net margin of -20.4%.